EYA1 and neuroblastoma: We utilized immunohistochemistry to examine the expression patterns of EYA1 in tissue microarrays (TMAs) composed of tissue samples collected from 98 individual patients, including 66 cases of neuroblastoma, and looked for correlation with standard-risk determining diagnostic factors.